Recombinant Interleukin-2 Therapy for Angiosarcoma of the Breast; Efficacy of Daily or Weekly Administration

Annals of Cancer Research and Therapy - United States
doi 10.4993/acrt1992.6.94
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The Japanese Society of Strategies for Cancer Research and Therapy

Related search

Proper Treatment of Breast Angiosarcoma-Mastectomy or Breast Conserving Surgery?

Breast Cancer Research and Treatment
Cancer ResearchOncology
2019English

Systemic Administration of Interleukin 2 Enhances the Therapeutic Efficacy of Dendritic Cell-Based Tumor Vaccines

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1999English

Angiosarcoma Causing Cardiac Constriction Late After Radiation Therapy for Breast Carcinoma

Texas Heart Institute Journal
MedicineCardiovascular MedicineCardiology
2016English

Daily Administration of Interleukin-18 Causes Myocardial Dysfunction in Healthy Mice

American Journal of Physiology - Heart and Circulatory Physiology
Cardiovascular MedicinePhysiologyCardiology
2005English

Clinical Efficacy and Treatment Persistence of Monthly Minodronate for Osteoporotic Patients Unsatisfied With, and Shifted From, Daily or Weekly Bisphosphonates: The BP-MUSASHI Study

Osteoporosis International
MedicineEndocrinologyMetabolismDiabetes
2014English

The Beneficial Effects of Adjunctive Recombinant Human Interleukin-2 for Multidrug Resistant Tuberculosis

Archives of Medical Science
Medicine
2015English

Adherence to GLP-1 Receptor Agonist Therapy Administered by Once-Daily or Once-Weekly Injection in Patients With Type 2 Diabetes in Germany

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Internal MedicinePharmacology
2016English

Molecular Predictors of Efficacy of Adjuvant Weekly Paclitaxel in Early Breast Cancer

Breast Cancer Research and Treatment
Cancer ResearchOncology
2009English

Lobular Panniculitis After Subcutaneous Administration of Interleukin-2 (IL-2), and Its Exacerbation During Intravenous Therapy With IL-2

British Journal of Cancer
Cancer ResearchOncology
1992English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy